Shanghai Pharmaceuticals Holding Co (S1R) Income Statement
Shanghai Pharmaceuticals Holding Co Income Statement
Last quarter (Q3 2026), Shanghai Pharmaceuticals Holding Co's total revenue was $75.48B, an increase of 2.76% from the same quarter last year. In Q3, Shanghai Pharmaceuticals Holding Co's net income was $1.08B. See Shanghai Pharmaceuticals Holding Co’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Mar 24 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 283.58B | $ 275.25B | $ 260.30B | $ 231.98B | $ 215.82B | |
| $ 30.42B | $ 30.63B | $ 30.93B | $ 30.49B | $ 28.54B | |
| $ 20.47B | $ 22.49B | $ 23.26B | $ 21.71B | $ 20.62B | |
| Depreciation and Amortization | $ 2.86B | $ 2.42B | $ 2.19B | $ 2.22B | $ 2.14B |
| $ 14.37B | $ 12.06B | $ 10.90B | $ 12.44B | $ 10.55B | |
| $ 9.94B | $ 8.14B | $ 7.67B | $ 9.01B | $ 8.21B | |
| $ -122.28M | $ -120.71M | $ -612.94M | $ -206.30M | $ -61.67M | |
| $ 9.82B | $ 8.02B | $ 7.05B | $ 8.81B | $ 8.14B | |
| $ 5.72B | $ 4.55B | $ 3.77B | $ 5.62B | $ 5.09B | |
| Per Share Metrics | |||||
| Basic EPS | $ 1.54 | $ 1.23 | $ 1.02 | $ 1.61 | $ 1.79 |
| Diluted EPS | $ 1.54 | $ 1.23 | $ 1.02 | $ 1.61 | $ 1.79 |
| Weighted Average Shares Outstanding | 3.71B | 3.70B | 3.70B | 3.48B | 2.84B |
| Weighted Average Shares Outstanding (Diluted) | 3.71B | 3.70B | 3.70B | 3.49B | 2.85B |
Currency in CNY
